Skip to main content

Table 1 Effect of oral administration of whey proteins products on final body weight, liver weight and hepatic index of rats fed the normal (control) and high carbohydrate, fat free (HCFFD) diets

From: Protective effect of whey proteins against nonalcoholic fatty liver in rats

 

Final body weight (g)

Liver weight (g)

Hepatic Index

Control

180.32 ± 21.66 a

6.27 ± 1.24ab

3.65 ± 0.73a

HCFFD

158.10 ± 25.77 ab

6.53 ± 1.27a

3.96 ± 0.35a

WPI

126.48 ± 18.90b

4.22 ± 0.99b

3.32 ± 0.50a

WPH

131.70 ± 13.79ab

4.30 ± 1.62ab

3.25 ± 0.45a

αLA

128.76 ± 22.88b

4.67 ± 0.85ab

3.66 ± 0.60a

βLG

121.07 ± 8.13b

4.53 ± 0.33 ab

3.74 ± 0.12a

GMP

155.19 ± 19.07ab

5.98 ± 1.15ab

3.85 ± 0.49a

  1. Mean values with their standard deviation for five rats per group
  2. WPI: whey protein isolate, WPH: whey protein hydrolysate, αLA: alpha lactalbumin, βLG: Beta lactoglobulin, GMP: glycomacropeptide.
  3. Means in a column without common letter are significantly differ, P < 0.05 (Tukey's test).